Soliris (eculizumab), an Orphan Drug, for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a very rare blood disorder, has been approved by the US Food and Drug Administration. PNH can lead to disability and premature death. Solaris is a new molecular entity containing an active ingredi...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
A study published March 17, 2007 in The Lancet, one of the world's foremost medical journals, finds that the chances of surviving a cardiac arrest outside a hospital setting are twice as high if bystanders perform chest-compression-only resuscitation instead of traditional cardiopulmonary resuscitat...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
With the number of carers for frail elderly people set to fall steeply, researchers in the BMJ propose a way to help plan for the deficit.Many people fear that population ageing will generate a demand for long term care that will outpace the supply of formal care. So to anticipate the future long te...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
With nanotechnology being described by business and government leaders as "The Next Industrial Revolution," the Woodrow Wilson International Center for Scholars and The Pew Charitable Trusts has announced they will expand their efforts to help industry, governments and the public reap nanotechnology...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine.But the results leave open the possibility that some medications, including ...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Calderdale and Huddersfield NHS Foundation Trust has extended its existing home grown Patient Administration System (PAS) from one site to three hospitals in just four months.
read more »
Source:http://www.e-health-insider.com DiscussBury
This year, Elsevier, a leading publisher of scientific, technical and medical (STM) information, is adding two new, groundbreaking Cell Press titles - Cell Host & Microbe and Cell Stem Cell - to its platform, ScienceDirect. To celebrate the launch, access to the first three issues of both journals i...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Apples may prove to be a winner when it comes to reducing the risk of heart disease, says a new study of more than 34,000 women. In this study, flavonoid-rich apples were found to be one of three foods (along with red wine and pears) that decrease the risk of mortality for both coronary heart diseas...
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.